Actively Recruiting
Post-Market Clinical Follow-Up Study on the Safety and Performance of Ennovate® Complex
Led by Aesculap AG · Updated on 2026-04-15
200
Participants Needed
2
Research Sites
345 weeks
Total Duration
On this page
Sponsors
A
Aesculap AG
Lead Sponsor
R
Raylytic GmbH
Collaborating Sponsor
AI-Summary
What this Trial Is About
Multicenter, multinational Post-Market Clinical Follow-Up (PMCF) study on the safety and performance of Ennovate® Complex - A prospective, pure data collection of all Ennovate® scoliosis patients in selected centers (not interventional, multicentric)
CONDITIONS
Official Title
Post-Market Clinical Follow-Up Study on the Safety and Performance of Ennovate® Complex
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Provide informed consent for documentation of clinical and radiological results if 18 years or older
- Provide informed consent along with legal representative (parent) if younger than 18 years old
- Have an indication for treatment according to the device's instructions for use
- Not be pregnant
You will not qualify if you...
- Clear inability or unwillingness to participate in follow-up examinations
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
University Hospital Brno
Brno, Czechia, 62500
Suspended
2
Hospital Universiti Kebangsaan Malaysia (HUKM)
Kuala Lumpur, Malaysia
Actively Recruiting
Research Team
S
Sarah Mattes
CONTACT
S
Stefan Maenz
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here